BroadLight Continues to Win GPON Designs

In response to growing customer demand for high-performance and low-cost GPON equipment, Enablence Technologies today announced that it will be expanding the use of BroadLight's end-to-end Gigabit Passive Optical Network Communications Controller Integrated Circuits (E2E GPON ICs) for its high-speed GPON residential gateways and optical networks terminals.

Enablence has been successfully shipping GPON products incorporating BroadLight’s BL2338 and BL2340 Communications Controller ICs and now will start using the BL2345 and the BL 2348 Communications Controllers ICs for expanding the Enablence GPON product portfolio of Optical Network Terminals (ONTs) and Residential Gateways. The Enablence Optical Line Terminal (OLT) platform currently incorporates BroadLight’s BL3458 Communications Controller ICs for Optical Line Terminals (OLTs).

“BroadLight is the clear market leader in the GPON space by delivering products that power the entire GPON system,” Bill Saunders, Enablence’s Vice President of Engineering. “We have had a long term relationship with BroadLight and as demand for our GPON equipment continues to expand the BroadLight’s IC solution was the best way to get to the market quickly with a low-cost and powerful GPON product line with Enablence’s own PLC based technology.”

“Our GPON communications controller IC product shipments are now ramping as we are seeing GPON becoming more pervasive throughout the access market,” said Didi Ivancovsky, Founder and VP of Marketing for BroadLight. “Our GPON communications controllers are enabling our customers to deliver complete GPON solutions at an attractive price point in all market segments.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.